Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FL0D2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,039
Award facts
- Contract value 100% obligated
- $26,038.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of November 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. The delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
Under the PPV-G GEN V contract vehicle, DMS Pharmaceutical Group holds a $499.999 billion single-award IDC with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The Mirena systems delivery order represents a component of the company's broader pharmaceutical supply portfolio, which encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning the company as a critical supplier within the federal military medical system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FL0D2?
SPE2DB26FL0D2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FL0D2 worth?
The government has obligated $26,039 on SPE2DB26FL0D2.
Is contract SPE2DB26FL0D2 an order under another contract?
Yes. SPE2DB26FL0D2 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB26FL0D2 competed?
The extent of competition for SPE2DB26FL0D2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award